Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: A 1H-MRS study

Autism Research

Volumn 6, Issue 1, 2013, Pages 1-10

  Brown, Mark S ^a,b   Singel, Debra ^a,b   Hepburn, Susan ^a,b   Rojas, Donald C ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Auditory cortex; Creatine; Glutamate; N acetyl aspartate; Spectroscopy

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; AUDITORY CORTEX; AUTISM; BRAIN LEVEL; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXCITABILITY; FEMALE; FIRST DEGREE RELATIVE; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; AUDITORY CORTEX; AUTISTIC DISORDER; CHOLINE; CREATINE; FEMALE; GLUTAMIC ACID; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PARENTS;

EID: 84874031142     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.1260     Document Type: Article

References (71)

1. Aoki, Y., Kasai, K., & Yamasue, H. (2012). Age-related change in brain metabolite abnormalities in autism: A meta-analysis of proton magnetic resonance spectroscopy studies. Translational Psychiatry, 2, e69.
2. Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I., etal. (1998). A clinicopathological study of autism. Brain: A Journal of Neurology, 121(Pt 5), 889-905.
3. Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley, E. (2001). The autism-spectrum quotient (AQ): Evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. Journal of Autism and Developmental Disorders, 31, 5-17.
4. Bauman, M., & Kemper, T.L. (1985). Histoanatomic observations of the brain in early infantile autism. Neurology, 35, 866-874.
5. Bauman, M., & Kemper, T.L. (1994). Neuroanatomic observations of the brain in autism. In M. Bauman & T.L. Kemper (Eds.), The neurobiology of autism (pp. 119-145). Baltimore, MD: Johns Hopkins University Press.
6. Bauman, M.L., & Kemper, T.L. (2005). Neuroanatomic observations of the brain in autism: A review and future directions. International Journal of Developmental Neuroscience, 23, 183-187.
7. Bejjani, A., O'Neill, J., Kim, J.A., Frew, A.J., Yee, V.W., etal. (2012). Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by(1)H MRS and (1)H MRSI. PLoS ONE, 7, e38786.
8. Bernardi, S., Anagnostou, E., Shen, J., Kolevzon, A., Buxbaum, J.D., etal. (2011). In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Research, 1380, 198-205.
9. Blatt, G.J., Fitzgerald, C.M., Guptill, J.T., Booker, A.B., Kemper, T.L., & Bauman, M.L. (2001). Density and distribution of hippocampal neurotransmitter receptors in autism: An autoradiographic study. Journal of Autism & Developmental Disorders, 31, 537-543.
10. Bustillo, J.R., Rowland, L.M., Jung, R., Brooks, W.M., Qualls, C., etal. (2008). Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia. Neuropsychopharmacology, 33, 2456-2466.
11. Chez, M.G., Burton, Q., Dowling, T., Chang, M., Khanna, P., & Kramer, C. (2007). Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: An observation of initial clinical response and maintenance tolerability. Journal of Child Neurology, 22, 574-579.
12. Chih, B. (2005). Control of excitatory and inhibitory synapse formation by neuroligins. Science, 307, 1324-1328.
13. Chugani, D.C., Sundram, B.S., Behen, M., Lee, M.L., & Moore, G.J. (1999). Evidence of altered energy metabolism in autistic children. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 23, 635-641.
14. Clark, J.B. (1998). N-acetyl apartate: A marker for neuronal loss or mitochondrial dysfunction. Developmental Neuroscience, 20, 271-276.
15. Coghlan, S., Horder, J., Inkster, B., Mendez, M.A., Murphy, D.G., & Nutt, D.J. (2012). GABA system dysfunction in autism and related disorders: From synapse to symptoms. Neuroscience and Biobehavioral Reviews, 36, 2044-2055.
16. Constantino, J.N., & Todd, R.D. (2005). Intergenerational transmission of subthreshold autistic traits in the general population. Biological Psychiatry, 57, 655-660.
17. DeVito, T.J., Drost, D.J., Neufeld, R.W., Rajakumar, N., Pavlosky, W., etal. (2007). Evidence for cortical dysfunction in autism: A proton magnetic resonance spectroscopic imaging study. Biological Psychiatry, 61, 465-473.
18. Dhossche, D., Applegate, H., Abraham, A., Maertens, P., Bland, L., etal. (2002). Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: Stimulus for a GABA hypothesis of autism. Medical Science Monitor, 8, PR1-PR6.
19. Endo, T., Shioiri, T., Kitamura, H., Kimura, T., Endo, S., etal. (2007). Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders. Biological Psychiatry, 62, 1030-1037.
20. Erickson, C.A., Early, M., Stigler, K.A., Wink, L.K., Mullett, J.E., & McDougle, C.J. (2011). An open-label naturalistic pilot study of acamprosate in youth with autistic disorder. Journal of Child and Adolescent Psychopharmacology, 21, 565-569.
21. Fatemi, S.H. (2008). The hyperglutamatergic hypothesis of autism. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32, 911; author reply 912-913.
22. Fatemi, S.H., Folsom, T.D., Kneeland, R.E., & Liesch, S.B. (2011). Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism. Anatomical Record (Hoboken), 294, 1635-1645.
23. Fatemi, S.H., Halt, A.R., Stary, J.M., Kanodia, R., Schulz, S.C., & Realmuto, G.R. (2002). Glutamic acid decarboxylase 65 and 67kDa proteins are reduced in autistic parietal and cerebellar cortices. Biological Psychiatry, 52, 805-810.
24. Fatemi, S.H., Reutiman, T.J., Folsom, T.D., & Thuras, P.D. (2009). GABA(A) receptor downregulation in brains of subjects with autism. Journal of Autism and Developmental Disorders, 39, 223-230.
25. Friedman, S.D., Shaw, D.W., Artru, A.A., Dawson, G., Petropoulos, H., & Dager, S.R. (2006). Gray and white matter brain chemistry in young children with autism. Archives of General Psychiatry, 63, 786-794.
26. Gabis, L., Wei, H., Azizian, A., DeVincent, C., Tudorica, A., etal. (2008). 1H-Magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders. Journal of Child Neurology, 23, 766-774.
27. Gandal, M.J., Edgar, J.C., Ehrlichman, R.S., Mehta, M., Roberts, T.P.L., & Siegel, S.J. (2010). Validating γ oscillations and delayed auditory responses as translational biomarkers of autism. Biological Psychiatry, 68, 1100-1106.
28. Gürkan, C.K., & Hagerman, R.J. (2012). Targeted treatments in autism and fragile X syndrome. Research in Autism Spectrum Disorders, 6, 1311-1320.
29. Harada, M., Taki, M.M., Nose, A., Kubo, H., Mori, K., etal. (2010). Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument. Journal of Autism and Developmental Disorders, 41, 447-454.
30. Hardan, A.Y., Minshew, N.J., Melhem, N.M., Srihari, S., Jo, B., etal. (2008). An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Research, 163, 97-105.
31. Hashimoto, T., Tayama, M., Miyazaki, M., Yoneda, Y., Yoshimoto, T., etal. (1997). Differences in brain metabolites between patients with autism and mental retardation as detected by in vivo localized proton magnetic resonance spectroscopy. Journal of Child Neurology, 12, 91-96.
32. Hisaoka, S., Harada, M., Nishitani, H., & Mori, K. (2001). Regional magnetic resonance spectroscopy of the brain in autistic individuals. Neuroradiology, 43, 496-498.
33. Hollingshead, A.B. (1975). Four factor index of social position. New Haven, CT: Yale University.
34. Hussman, J.P. (2001). Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. Journal of Autism and Developmental Disorders, 31, 247-248.
35. Jacob, S., Brune, C.W., Badner, J.A., Ernstrom, K., Courchesne, E., etal. (2011). Family-based association testing of glutamate transporter genes in autism. Psychiatric Genetics, 21, 212-213.
36. Kaiser, L.G., Schuff, N., Cashdollar, N., & Weiner, M.W. (2005). Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 T. Neurobiology of Aging, 26, 665-672.
37. Kaymak, S.U., Demir, B., Oguz, K.K., Senturk, S., & Ulug, B. (2009). Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naive female patients with first-episode major depression. Psychiatry and Clinical Neurosciences, 63, 350-356.
38. Kielinen, M., Rantala, H., Timonen, E., Linna, S.L., & Moilanen, I. (2004). Associated medical disorders and disabilities in children with autistic disorder: A population-based study. Autism, 8, 49-60.
39. Kleinhans, N.M., Richards, T., Weaver, K.E., Liang, O., Dawson, G., & Aylward, E. (2009). Brief report: Biochemical correlates of clinical impairment in high functioning autism and Asperger's disorder. Journal of Autism and Developmental Disorders, 39, 1079-1086.
40. Kogan, M.D., Blumberg, S.J., Schieve, L.A., Boyle, C.A., Perrin, J.M., etal. (2009). Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics, 124, 1395-1403.
41. Levitt, J.G., O'Neill, J., Blanton, R.E., Smalley, S., Fadale, D., etal. (2003). Proton magnetic resonance spectroscopic imaging of the brain in childhood autism. Biological Psychiatry, 54, 1355-1366.
42. Lord, C., Risi, S., Lambrecht, L., Cook, E.H., Leventhal, B.L., etal. (2000). The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30, 205-223.
43. Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 25, 659-685.
44. Losh, M., Childress, D., Lam, K., & Piven, J. (2008). Defining key features of the broad autism phenotype: A comparison across parents of multiple- and single-incidence autism families. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147B, 424-433.
45. Murphy, D.G., Critchley, H.D., Schmitz, N., McAlonan, G., Van Amelsvoort, T., etal. (2002). Asperger syndrome: A proton magnetic resonance spectroscopy study of brain. Archives of General Psychiatry, 59, 885-891.
46. O'Brien, F.M., Page, L., O'Gorman, R.L., Bolton, P., Sharma, A., etal. (2010). Maturation of limbic regions in Asperger syndrome: A preliminary study using proton magnetic resonance spectroscopy and structural magnetic resonance imaging. Psychiatry Research, 184, 77-85.
47. Otsuka, H., Harada, M., Mori, K., Hisaoka, S., & Nishitani, H. (1999). Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: An 1H-MR spectroscopy study. Neuroradiology, 41, 517-519.
48. Page, L.A., Daly, E., Schmitz, N., Simmons, A., Toal, F., etal. (2006). In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. The American Journal of Psychiatry, 163, 2189-2192.
49. Provencher, S.W. (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine, 30, 672-679.
50. Psychological Corporation. (1999). The Wechsler abbreviated scale of intelligence. San Antonio, TX: Harcourt Brace and Company.
51. Purcell, A.E., Jeon, O.H., Zimmerman, A.W., Blue, M.E., & Pevsner, J. (2001). Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology, 57, 1618-1628.
52. Ritvo, E.R., Freeman, B.J., Scheibel, A.B., Duong, T., Robinson, H., etal. (1986). Lower Purkinje cell counts in the cerebella of four autistic subjects: Initial findings of the UCLA-NSAC Autopsy Research Report. The American Journal of Psychiatry, 143, 862-866.
53. Rojas, D.C., Maharajh, K., Teale, P., & Rogers, S.J. (2008). Reduced neural synchronization of gamma-band MEG oscillations in first-degree relatives of children with autism. BMC Psychiatry, 8, 66. DOI: 10.1186/1471-244X-8-66
54. Rojas, D.C., Teale, P., Sheeder, J., Simon, J., & Reite, M. (1997). Sex-specific expression of Heschl's gyrus functional and structural abnormalities in paranoid schizophrenia. The American Journal of Psychiatry, 154, 1655-1662.
55. Rojas, D.C., Teale, P.D., Maharajh, K., Kronberg, E., Youngpeter, K., etal. (2011). Transient and steady-state auditory gamma-band responses in first-degree relatives of people with autism spectrum disorder. Molecular Autism, 2, 11.
56. Rubenstein, J.L., & Merzenich, M.M. (2003). Model of autism: Increased ratio of excitation/inhibition in key neural systems. Genes, Brain, and Behavior, 2, 255-267.
57. Sailasuta, N., Ernst, T., & Chang, L. (2008). Regional variations and the effects of age and gender on glutamate concentrations in the human brain. Magnetic Resonance Imaging, 26, 667-675.
58. Schaefer, G.B., & Lutz, R.E. (2006). Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genetics in Medicine, 8, 549-556.
59. Shinohe, A., Hashimoto, K., Nakamura, K., Tsujii, M., Iwata, Y., etal. (2006). Increased serum levels of glutamate in adult patients with autism. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, 1472-1477.
60. Soares, D.P., & Law, M. (2009). Magnetic resonance spectroscopy of the brain: Review of metabolites and clinical applications. Clinical Radiology, 64, 12-21.
61. Szatmari, P., Paterson, A.D., Zwaigenbaum, L., Roberts, W., Brian, J., etal. (2007). Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics, 39, 319-328.
62. Szulc, A., Galinska, B., Tarasow, E., Waszkiewicz, N., Konarzewska, B., etal. (2011). Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment. Pharmacopsychiatry, 44, 148-157.
63. Taylor, M.J., Norbury, R., Murphy, S., Rudebeck, S., Jezzard, P., & Cowen, P.J. (2010). Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers. Journal of Psychopharmacology, 24, 1217-1221.
64. Tuchman, R., Cuccaro, M., & Alessandri, M. (2010). Autism and epilepsy: Historical perspective. Brain and Development, 32, 709-718.
65. Urenjak, J., Williams, S.R., Gadian, D.G., & Noble, M. (1993). Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. Journal of Neuroscience, 13, 981-989.
66. van der Knaap, M.S., van der Grond, J., van Rijen, P.C., Faber, J.A., Valk, J., & Willemse, K. (1990). Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology, 176, 509-515.
67. Vasconcelos, M.M., Brito, A.R., Domingues, R.C., da Cruz, L.C.H., Gasparetto, E.L., etal. (2008). Proton magnetic resonance spectroscopy in school-aged autistic children. Journal of Neuroimaging, 18, 288-295.
68. Virkud, Y.V., Todd, R.D., Abbacchi, A.M., Zhang, Y., & Constantino, J.N. (2009). Familial aggregation of quantitative autistic traits in multiplex versus simplex autism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 150B, 328-334.
69. Wilson, T.W., Rojas, D.C., Reite, M.L., Teale, P.D., & Rogers, S.J. (2007). Children and adolescents with autism exhibit reduced MEG steady-state gamma responses. Biological Psychiatry, 62, 192-197.
70. Yip, J., Soghomonian, J.J., & Blatt, G.J. (2007). Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: Pathophysiological implications. Acta Neuropathol, 113, 559-568.
71. Zeegers, M., van der Grond, J., van Daalen, E., Buitelaar, J., & van Engeland, H. (2007). Proton magnetic resonance spectroscopy in developmentally delayed young boys with or without autism. Journal of Neural Transmission, 114, 289-295.